News

An update from Schär regarding supply of samples and literature for healthcare professionals in light of the evolving COVID-19 situation.

This article looks to provide a brief overview of the clinical guidelines and highlight the updates that have been made in the area of gluten-related disorders.

The Dr. Schär Nutrition Service Team is delighted to announce it has updated its first and second-line dietary advice booklets for use with Irritable Bowel Syndrome (IBS) patients.

Glutafin’s Nutrition Service Team has produced a detailed summary of the changes proposed for gluten-free prescriptions in England and the practical implications of these across the UK. Key dates for the implementation of these changes, alongside a full list of Glutafin products and availability in England and the devolved nations are also provided here.

A consensus document on role of exclusion diets in IBS has been developed to help facilitate dietary counselling in daily practice.

The prevalence of coeliac disease (CD) has rapidly increased over recent decades, but costs related to CD remain poorly quantified. The purpose of this systematic review was to assess the economic burden of CD in North America and Europe.

We are pleased to report the publication of our most recent Forum journal, a special issue dedicated to the nutritional quality and safety of manufactured gluten-free foods and implications for health and disease.